CGON•benzinga•
CG Oncology's Bladder Cancer Drug Impresses Investors - Here's Why
Summary
CG Oncology shared new Phase 3 trial results showing durable responses and strong patient compliance in high-risk bladder cancer treatment at AUA 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga